| Symbol: |
CYP2C19
|
| Description: |
cytochrome P450, family 2, subfamily C, polypeptide 19 [Source:HGNC Symbol;Acc:2621]
|
| Location: |
Chr10:96447911-96613017[+]
|
| CRmiRSNP:
~ Export ~
|
Records:null
| Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
| Compound:
~ Export ~
|
Records:338
| Gene |
Compound |
Gen_sig |
Exp_pattern |
| CYP2C19 |
2-[(Dimethylamino)-1-ethyl]-5,6-dihydro-2,3-dimethoxy-8,9-me thylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Formic Acid |
0.027 |
Down |
| CYP2C19 |
6-[3-(Bis-hydroxyethylamino)-1-propyl]-5,6-dihydro-2,3-~ dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride |
0.027 |
Down |
| CYP2C19 |
6-[(3-Thiazolylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-~ 8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride |
0.001 |
Down |
| CYP2C19 |
2,2'-(1,4-phenylene)bis(1,3-dimethylimidazolidine) |
0.023 |
Down |
| CYP2C19 |
1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one |
0.007 |
Down |
| CYP2C19 |
6-(3-Aminopropyl)-5,6-dihydro-8,9-methylenedioxy-5,11-dioxo- 3-nitro-11H-indeno[1,2-c]isoquinoline Hydrochloride Salt |
0.008 |
Down |
| CYP2C19 |
Dasatinib |
0.007 |
Up |
| CYP2C19 |
NSC 732719 |
0.002 |
Down |
| CYP2C19 |
gamma-glutamyl-alpha-amino-beta-[[2-ethyl(5-fluoro-2'deoxyur idyl) N-methyl-N-(4-chlorobutyl)phosphoramidoyl]sulfonyl] propionyl-(R)-(-)-phenylglycine |
0.001 |
Down |
| CYP2C19 |
NSC 734631 |
0.04 |
Down |
| CYP2C19 |
Ethyl 4-[6-(2-furyl)-2-(methylsulfanyl)-4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-3-yl]butanoate |
0.047 |
Up |
| CYP2C19 |
6-(3-Bromopropyl)-5,6-dihydro-9-methyl-3-nitro-5,11-dioxo-11 H-indeno[1,2-c]isoquinoline |
0.013 |
Down |
| CYP2C19 |
NSC 736021 |
0.048 |
Up |
| CYP2C19 |
4-[(Z)-2-(5-nitro-2-furyl)ethenyl]-6-(4-phenylpiperazin-1-yl )-1,3,5-triazin-2-ylamine |
0.005 |
Down |
| CYP2C19 |
6-(3-Aminopropyl)-5,6-dihyro-9-iodo-3-nitro-5,11-dioxo-11H-i ndeno[1,2-c]isoquinoline Hydrochloride |
0.022 |
Down |
Expression pattern: Sensitivity / Resistance
Total:23 Current:21
First Prev Next Last
|
| SNP:
~ Export ~
|
Records:null
| SNP |
Gene |
SNP_location |
SNP_allele |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
| miRNA:
~ Export ~
|
Records:56
| Gene |
Gen_transcript |
miRNA |
miR_location |
| CYP2C19 |
ENST00000371321 |
hsa-let-7a-3p |
Chr22:46508680-46508700[+] |
| CYP2C19 |
ENST00000371321 |
hsa-let-7a-3p |
Chr9:96938295-96938315[+] |
| CYP2C19 |
ENST00000371321 |
hsa-mir-101-5p |
Chr1:65524160-65524181[-] |
| CYP2C19 |
ENST00000371321 |
hsa-mir-124-3p |
Chr20:61809904-61809923[+] |
| CYP2C19 |
ENST00000371321 |
hsa-mir-124-3p |
Chr8:65291767-65291786[+] |
| CYP2C19 |
ENST00000371321 |
hsa-mir-124-3p |
Chr8:9760911-9760930[-] |
| CYP2C19 |
ENST00000371321 |
hsa-mir-125b-1-3p |
Chr11:121970477-121970498[-] |
| CYP2C19 |
ENST00000371321 |
hsa-mir-125b-2-3p |
Chr21:17962610-17962631[+] |
| CYP2C19 |
ENST00000371321 |
hsa-mir-128 |
Chr2:136423016-136423036[+] |
| CYP2C19 |
ENST00000371321 |
hsa-mir-128 |
Chr3:35786019-35786039[+] |
| CYP2C19 |
ENST00000371321 |
hsa-mir-143-5p |
Chr5:148808507-148808528[+] |
| CYP2C19 |
ENST00000371321 |
hsa-mir-153 |
Chr2:220158848-220158869[-] |
| CYP2C19 |
ENST00000371321 |
hsa-mir-153 |
Chr7:157367041-157367062[-] |
| CYP2C19 |
ENST00000371321 |
hsa-mir-155-5p |
Chr21:26946295-26946317[+] |
| CYP2C19 |
ENST00000371321 |
hsa-mir-15a-3p |
Chr13:50623266-50623287[-] |
Total:4 Current:1
[First] [Prev] Next Last
|